MetalDrug simulates and scores molecular behavior using tiered AI logic, turning chemical potential into therapeutic intelligence.
MetalDrug operates at the frontier of deterministic molecular engineering. Our core system—comprising MDC, FDC, and the Moleculogic Engine—functions as a tiered, logic-verified simulation and generation platform for designing novel therapeutic compounds.
Explore the Moleculogic approach through this interactive visualization. Click on a molecule type below to see different structures and their logical frameworks.
Coordination-driven therapeutic design leveraging metal-ligand interactions for programmable drug behavior. The metal center acts as a logic hub that responds to specific environmental triggers like pH and redox potential.
pH < 6.5
ROS > 100 μM
Ligand Release + Metal Activation
MetalDrug offers a structured access model designed to accommodate different user needs, from public exploration to secure co-development environments.
Public read-only access to daily blueprints and simplified molecular visualization.
Secure environment for blueprint creation, simulation, and validation with NDA protection.
Advanced features for scientific teams with reviewer feedback and collaboration tools.
Full partnership tier with licensing options, co-development, and commercialization support.
Explore the latest molecular blueprints generated by our Moleculogic Engine Discovery system.
A zinc-centered coordination complex with dual pH and ROS responsive ligand release mechanism, designed for targeted tumor microenvironment activation.
Our approach ensures transparency, traceability, and regulatory readiness for pharmaceutical partners.
Whether you're a researcher, investor, or pharmaceutical partner—MetalDrug invites you to step into the future of deterministic molecular engineering.